Krsnaa Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2026 ,inter alia, to consider and approve the Unaudited Financial Results for the Quarter and Half Year ended September 30th, 2026

Date: October 26, 2026 Ref. No.: KDL/SE/060/2026-27 To, To, BSE Limited National Stock Exchange of India Limited Corporate Relationship Department Exchange Plaza, Plot No. C-1, Block G, 25th Floor, Phiroze Jeejeebhoy Towers Bandra Kurla Complex, Bandra (East) Dalal Street, Mumbai- 400001 Mumbai – 400051 Scrip Code: 543328 NSE Symbol: KRSNAA Subject: Intimation of Board Meeting under Regulation 29(1) & (2) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 Pursuant to the provisions of Regulation 29(1) & (2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Monday, November 02, 2026 inter-alia to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and half year ended September 30, 2026. This intimation is also being uploaded on the Company’s website at https://krsnaadiagnostics.com/investors/. It is requested to take the same on your records Thanking you, Yours sincerely, For Krsnaa Diagnostics Limited Sujoy Sudipta Bose Company Secretary and Compliance Officer